Lyell Pharma (LYEL) - Market Cap to Net Income Ratio

Corporate emblem and logo of Lyell Immunopharma Inc (LYEL)

The price trajectory of Lyell Immunopharma (LYEL) demonstrates the -1.30 indicator, while the company strictly monitors facility cleanliness and biohazardous waste disposal. The operating model relies on external contractors to conduct tests and manufacture drugs. Business development is driven by leading scientists, who are attracted by large-scale research investments and stock option programs.

LYEL lyell.com: Price to Earnings Ratio in the range 07/04/2022 - 11/18/2026

Analytical breakdowns for Lyell Immunopharma

Comprehensive company analysis:LYEL Lyell Immunopharma Inc
Manufactured product of Lyell Immunopharma

For Lyell Immunopharma (LYEL), whose valuation depends on success in T-cell rejuvenation, the company's quarterly P/E ratio serves as an indicator of market expectations. This multiple compares current market capitalization with net income, determining the cost of one dollar of earnings. The calculation allows for the identification of asset overvaluation or the risk of capital freezing in the event of inflated expectations. Analyzing this metric helps distinguish speculative growth from the issuer's fundamental stability prior to the publication of trial data.

Competing companies

Market Cap to Earnings ImmunityBio IBRX|P/E Multiple IMCR|Janux Therapeutics (JANX) - Market Cap to Net Income Ratio|Arcus Biosciences Inc - Price to Earnings Ratio|Zymeworks (ZYME) - Market Cap to Earnings|TNGX: Price to Earnings Ratio|Company Value to Net Income IOVA (Iovance Biotherapeutics, Inc.)|IMTX: P/E Multiple|XNCR - Business Payback Period|Price to Earnings Ratio compasstherapeutics.com|Price to Earnings Ratio replimune.com (REPL)|Price to Earnings Ratio Innate Pharma SA (IPHA)|Price to Earnings Ratio Pyxis PYXS|Compugen Ltd - Price to Earnings Ratio|P/E Multiple IO Biotech Inc. IOBT|STRO - Price to Earnings Ratio|INKT (minktherapeutics.com) - Price to Earnings Multiple|werewolftx.com (HOWL) - Price to Earnings Ratio|Market Cap to Earnings Immix Biopharma, Inc. (IMMX)|Price to Earnings Ratio ALXO|CUE (Cue Biopharma, Inc.) - Market Price to Net Income Ratio|Price to Earnings Ratio PDSB (PDS Biotechnology)|Market Price to Net Income Ratio SONN|P/E Multiple MAIA (MAIA Biotechnology, Inc.)|Company Value to Net Income LIMN|Lava Tx - P/E Multiple|Market Cap to Earnings NextCure Corporation|Leap Tx (LPTX) - Price to Earnings Ratio|Intensity Therapeutics Inc - Company Value to Net Income|SNSE (Sensei Bio) - P/E Multiple|P/E Multiple Theriva Biologics Inc|Price to Earnings Ratio gritstonebio.com (GRTS)|P/E Multiple Kineta Bio (KA)|NexImmune Inc - Price to Earnings Ratio|turnstonebio.com (TSBX) - Market Cap to Earnings|VCNX: Price to Earnings Ratio|Company Value to Net Income HARP (Harpoon Therapeutics, Inc.)